Yahoo! Fresenius' Pilot-Study News Good, Not Bad, for Affy
By Randy Osborne
Friday, February 15, 2013
Affymax Inc.'s morning Wall Street sell-off reversed itself by the afternoon on Thursday, as shareholders began to understand what the decision by dialysis firm Fresenius Medical Care North America in contract negotiations with Affymax really meant.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.